Ken André OLAUSSEN
机构: Maître de conférences (Associate Professor), University of Paris Sud
每年引用次数
引用次数
引用: 7,036
H-指数: 35
I10-指数 : 53
出版物: 110
High ALK gene copy number as a predictor of response to crizotinib in non-small cell lung cancer cell lines
Khadija Kalai , David Planchard , Nathalie Auger , Frederic Commo
Cancer Research 72 ( 8_Supplement) 1715 -1715
1
2012
OA06. 05 Proteomic Analysis of ERCC1 Predicts Benefit of Platinum Therapy in NSCLC: A Reevaluation of Samples from the TASTE Trial
Jean-Charles Soria , Ken Olaussen , Fabiola Cecchi , Eunkyung An
Journal of Thoracic Oncology 12 ( 1) S265 -S266
2017
Loss of USP1 translational control as a targetable cisplatin resistance mechanism in non-small cell lung cancer (NSCLC)
Carole Helissey , Tony Sourisseau , Hélène Mahieu , Céline Lefebvre
Cancer Research 75 ( 15_Supplement) 758 -758
2015
HIGH ALK GENE COPY NUMBER IS A FREQUENT EVENT IN NON-SMALL CELL TUMORS AND CELL LINES OF LUNG CANCER
Khadija Kalai , Nathalie Auger , Ludovic Lacroix , Nicolas Dorvault
JOURNAL OF THORACIC ONCOLOGY 6 ( 6) S1081 -S1081
2011
DNA damage response correlates with telomere shortening and telomeric proteins down regulation in the colorectal multistep process
Christophe Raynaud , Se Jin Jang , Paolo Nuciforo , Sylvie Lantuejoul
Cancer Research 68 ( 9_Supplement) 588 -588
2008
Arguments pour l’intégration des biomarqueurs théranostiques de la réparation de l’ADN en pratique clinique dans le cancer bronchopulmonaire
Tony Sourisseau , Ken Olaussen , Jean-Charles Soria
ERCC1 and RRM1: Ready for Prime Time?
Benjamin Besse , Ken A. Olaussen , Jean-Charles Soria
Journal of Clinical Oncology 31 ( 8) 1050 -1060
64
2013
Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?
Gonzalo Recondo , Francesco Facchinetti , Ken A. Olaussen , Benjamin Besse
Nature Reviews Clinical Oncology 15 ( 11) 694 -708
102
2018
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy
Gonzalo Recondo , Linda Mahjoubi , Aline Maillard , Yohann Loriot
npj Precision Oncology 4 ( 1) 27 -27
2020
Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer.
Judith Michels , Ilio Vitale , Laura Senovilla , David P. Enot
Cell Cycle 12 ( 6) 877 -883
36
2013
MMS19 as a potential predictive marker of adjuvant chemotherapy benefit in resected non-small cell lung cancer.
Julien Adam , Tony Sourisseau , Ken A. Olaussen , Angélique Robin
Cancer Biomarkers 17 ( 3) 323 -333
2
2016
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade
Ludovic Bigot , Julien Adam , Jessica R. Frankum , Sylvère Durand
Journal of Clinical Investigation 128 ( 4) 1671 -1687
11
2018
A novel antibody-based approach to detect the functional ERCC1-202 isoform
Mei-Shiue Kuo , Julien Adam , Nicolas Dorvault , Angélique Robin
DNA Repair 64 34 -44
3
2018
ERCC1-Specific Immunostaining in Non–Small-Cell Lung Cancer
Ken A. Olaussen , Pierre Fouret , Guido Kroemer
The New England Journal of Medicine 357 ( 15) 1559 -1561
44
2007
A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib.
Thibault de La Motte Rouge , Lorenzo Galluzzi , Ken A. Olaussen , Yael Zermati
Cancer Research 67 ( 13) 6253 -6262
118
2007
Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer.
Siddhartha Devarakonda , Federico Rotolo , Ming-Sound Tsao , Irena Lanc
Journal of Clinical Oncology 36 ( 30) 2995 -3006
88
2018
Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAFV600E non-small cell lung cancer.
Francesco Facchinetti , Ludovic Lacroix , Laura Mezquita , Jean-Yves Scoazec
European Journal of Cancer 132 211 -223
53
2020
The potential of exploiting DNA-repair defects for optimizing lung cancer treatment
Sophie Postel-Vinay , Elsa Vanhecke , Ken A. Olaussen , Christopher J. Lord
Nature Reviews Clinical Oncology 9 ( 3) 144 -155
82
2012
19q13-ERCC1 gene copy number increase in non--small-cell lung cancer.
Elsa Vanhecke , Alexander Valent , Ximing Tang , Philippe Vielh
Clinical Lung Cancer 14 ( 5) 549 -557
9
2013
Abstract PL05-01: ERCC1 alternative readouts
Mei-Shiue Kuo , Ken A. Olaussen , Jean-Charles Soria
Molecular Cancer Therapeutics 14
2015